Search 
Thursday, August 28, 2008 ..:: Clinical Trials ::.. Register  Login
 Clinical Trials Minimize
 Print   
 Search Trials Minimize
 Print   
 Archives Minimize
Study Number:

Search
  
 Most Recent Entries Minimize
All Programs
All Sites - Prevention & Control (101170)
Sponsor: RTOG (0517)

 		By All Programs on 8/28/2008 4:00 AM
Randomized Phase Iii Trial To Evaluate Radiopharmaceuticals And Zoledronic Acid In The Palliation Of Osteoblastic Metastases From Lung, Breast, And Prostate Cancer

HIPAA Authorization
Informed Consent
Protocol
More...
BMT
Multiple Sites (100715)
Sponsor: MUSC (100715)

 		By BMT on 8/28/2008 4:00 AM
Allogenic Hematopoietic Stem Cell Transplantation with Reduced-Intensity Pre-transplant Conditioning for Patients Not Suitable for Full-Dose Pre-transplant Conditioning

None Available
More...
Breast
Breast (100899)
Sponsor: RTOG (0413)

 		By Breast on 8/28/2008 4:00 AM
A Radomized Phase III Study of Conventional Whole Breast Irradiation (WBI) Vs Partial Breast Irradiation (PBI) for Women with Stage 0, I, or II Breast Cancer

HIPAA Authorization
Informed Consent - Intervention
Protocol
More...
Breast
Breast (100953)
Sponsor: MUSC (100953)

 		By Breast on 8/28/2008 4:00 AM
Myeloid Suppressor Cells in Breast Cancer

None Available
More...
Breast
Breast (101020)
Sponsor: Sanofi-Aventis (TCD6511)

 		By Breast on 8/28/2008 4:00 AM
A Dose-Escalating, Multicenter, Single Arm, Open-Label Study of XRP9881 in Combination with Capecitabine (Xeloda), in Metastatic Breast Cancer Patients with Disease Progressing After Anthracycline and Taxane Therapy

HIPAA Authorization
Informed Consent
Protocol
More...
Breast
Breast (101072)
Sponsor: Novelos (101072)

 		By Breast on 8/28/2008 4:00 AM
Phase II Study of Neoadjuvant Chemotherapy with NOV-002 and AC Followed by Docetaxel in Patients with Stage IIB-IIIC Breast Cancer

HIPAA Authorization
Informed Consent
Protocol
More...
Breast
Breast (101136)
Sponsor: GlaxoSmithKilne (VEG108838)

 		By Breast on 8/28/2008 4:00 AM
A Randomized, Multicenter, Phase III Study Comparing the Combination of Pazopanib and Lapatinib versus Lapatinib Monotherapy in Patients with ErbB2 over-expressing Inflammatory Breast Cancer

HIPAA Authorization
Informed Consent
Informed Consent #2-Intervention
Informed Consent - Blood
Protocol
More...
Breast
Breast (101171)
Sponsor: CTSU/ECOG (PACCT-1)

 		By Breast on 8/28/2008 4:00 AM
Program for the Assessment of Clinical Cancer Tests (PACCT-1): Trial Assigning IndividuaLized Options for Treatment: The TAILORx Trial

HIPAA Authorization
Informed Consent
Protocol
More...
Breast
Breast (101172)
Sponsor: SWOG (S0622)

 		By Breast on 8/28/2008 4:00 AM
Phase II Studies of Two Different Schedules of Dasatinib (NSC-732517) in Bone-Metastasis Predominant Metastatic Breast Cancer

HIPAA Authorization
Informed Consent
Protocol
More...
Breast
Breast (101203)
Sponsor: CTSU/ECOG (E5103)

 		By Breast on 8/28/2008 4:00 AM
A Double-Blind Phase III Trial of Doxorubicin and Cyclophosphamide followed by Paclitaxel with Bevacizumab or Placebo in Patients with Lymph Node Positive and High Risk Lymph Node Negative Breast Cancer

HIPAA Authorization
Informed Consent
Protocol
More...
 Print   
Copyright 2007 by Hollings Cancer Center   Terms Of Use  Privacy Statement